Cybin Inc. CYBN
Set alert
At close · Jan 2
After hours · Jan 2, 4:00 PM ET
- YTD
- +1.22%
- 1 year
- -12.01%
- Open
- 8.28
- Prev close
- 8.28
- Mkt cap
- 190.72M
- Vol
- 716.53K
- Avg vol
- 352.19K
- EPS
- -5.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.14
- High
- 8.38
- Forward P/E
- -1.98
- Beta
- 0.89
- Short ratio
- 4.07
- Inst. own
- 36.61%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 10.44
- 200-d avg
- 11.48
- 1y target
- 101.46
Discussion (223)
Sign in to join the discussion
$CYBN careful of the honey trap.
$CYBN watch out for the trap second half of the day.
$CYBN why the hell Doug isn’t using the pay he gets from us investors to purchase shares of his own company he is CEO of ,especially at this discounted value?
$CYBN management is worthless.
POLITICSNew Bipartisan Congressional Bill Would Create Psychedelics-Focused VA Research Centers To Explore Treatment For Veterans. $CYBN https://www.marijuanamoment.net/new-bipartisan-congressional-bill-would-create-psychedelics-focused-va-research-centers-to-explore-treatment-for-veterans/
$CYBN something is happening, after hours volume is crazy.,
$CYBN and sector getting real attention now, even 60 minutes today just did story on psychedelics. https://youtu.be/a6ZTo4f2koc?si=c_Tna8OHkM4uB-uh
$CYBN is a steal at these prices for what’s in the pipeline coming.
@CYBN @PSIL about to take off. There’s too many positive catalysts in the works and so much money & support behind it. Last big raise few months ago $150MM from private placement that was oversubscribed, having plenty of cash to finish the rest of the studies. Phase II studies are remarkable on the 70%+ from depression remission rates, better than most antidepressants.